Literature DB >> 1396013

Pathogenesis of the atherosclerotic lesion. Implications for diabetes mellitus.

C J Schwartz1, A J Valente, E A Sprague, J L Kelley, A J Cayatte, M M Rozek.   

Abstract

In this review, we have highlighted pivotal cellular and molecular events in the initiation and progression of atherosclerosis. Key components of lesion initiation are an enhanced focal intimal influx and accumulation of lipoproteins, including LDL in hemodynamically determined lesion-prone areas, focal monocyte-macrophage recruitment, intimal generation of ROS, and oxidative modification of lipoproteins (including LDL [Ox-LDL]). Modified lipoproteins are taken up by the non-downregulating macrophage scavenger receptor, with foam cell formation and the development of the so-called fatty streak. One transitional event in lesion progression is foam cell necrosis, likely attributable to the cytotoxicity of both intimal free radicals and Ox-LDL, with development of an extracellular metabolically inert lipid core. Another is the migration to and proliferation within the intima of medial SMCs, leading to the synthesis of plaque collagens, elastin, and proteoglycans. Mural thrombosis plays a significant role in the late-stage progression of lesions. Regression of lesions is considered a function of the dynamic balance among components of initiation, progression, plaque stabilization, and removal of plaque constituents--the so-called regression quartet. Here, we critically examine how components of diabetes mellitus might impact not only lesion development, but also lesion regression. It is concluded that some components of diabetes mellitus augment key mechanisms in lesion initiation and progression and will likely retard the processes of plaque regression. Specifically, we focus on the various influences of diabetes mellitus on lipoprotein influx and accumulation, free radical generation and Ox-LDL, monocyte-macrophage recruitment, thrombosis and impaired fibrinolysis, and the reverse cholesterol transport system. The importance of nonenzymatic protein glycosylation in modifying a number of these processes is emphasized.

Entities:  

Mesh:

Year:  1992        PMID: 1396013     DOI: 10.2337/diacare.15.9.1156

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  19 in total

1.  Metformin restores the correlation between serum-oxidized LDL and leptin levels in type 2 diabetic patients.

Authors:  Manouchehr Nakhjavani; Afsaneh Morteza; Firuzeh Asgarani; Abnoos Mokhtari; Alireza Esteghamati; Omid Khalilzadeh; Ghazaleh Rahbari
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

2.  The pathomorphological alterations of endocardial endothelium in experimental diabetes and diabetes associated with hyperlipidemia.

Authors:  D Popov; A Sima; D Stern; M Simionescu
Journal:  Acta Diabetol       Date:  1996-03       Impact factor: 4.280

3.  Pathobiochemistry of combined diabetes and atherosclerosis studied on a novel animal model. The hyperlipemic-hyperglycemic hamster.

Authors:  M Simionescu; D Popov; A Sima; M Hasu; G Costache; S Faitar; A Vulpanovici; C Stancu; D Stern; N Simionescu
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

4.  Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study.

Authors:  M Capek; C Schnack; B Ludvik; A Kautzky-Willer; M Banyai; R Prager
Journal:  Clin Investig       Date:  1994-12

5.  Phenotypic modulation of cultured vascular smooth muscle cells: a functional analysis focusing on MLC and ERK1/2 phosphorylation.

Authors:  M A Carrillo-Sepúlveda; M L M Barreto-Chaves
Journal:  Mol Cell Biochem       Date:  2010-04-18       Impact factor: 3.396

6.  QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up.

Authors:  C Stettler; A Bearth; S Allemann; M Zwahlen; L Zanchin; M Deplazes; E R Christ; A Teuscher; P Diem
Journal:  Diabetologia       Date:  2006-11-10       Impact factor: 10.122

7.  Chronic hyperglicemia and nitric oxide bioavailability play a pivotal role in pro-atherogenic vascular modifications.

Authors:  Assunta Pandolfi; Elena Anna De Filippis
Journal:  Genes Nutr       Date:  2007-10-17       Impact factor: 5.523

8.  Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study.

Authors:  O Samuelsson; K Pennert; O Andersson; G Berglund; T Hedner; B Persson; H Wedel; L Wilhelmsen
Journal:  BMJ       Date:  1996-09-14

9.  Pathophysiology and Medical Treatment of Carotid Artery Stenosis.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2015-06-23

10.  Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome.

Authors:  P L Sanchez; J L Morinigo; P Pabon; F Martin; I Piedra; I F Palacios; C Martin-Luengo
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.